Will this be applicable to stroke? A very simple question. Whom the fuck do we go to to get it answered?
Influence of Neiromidin® on cognitive functions and neuroplasticity processes in traumatic brain injury
Abstract
Mild and moderate traumatic brain injury (TBI) is one of the most
common diseases in neurotraumatology and an important problem of modern
healthcare in all countries. The results of our work give grounds to
conduct comprehensive pathogenetic prevention and treatment of detected
cognitive impairment in patients already in the acute period of TBI in
order to prevent their progression in the future. A higher level of
brain glial neurotrophic factor — nerve growth factor beta — in the
blood serum of patients receiving Neiromidin® indicated the active
influence of the drug on the stimulation of neuroplasticity processes in
traumatic brain injury. The demonstrated clinical efficacy of
Neiromidin® allows us to recommend its inclusion in the schemes of
standard therapy for TBI. And its administration in the acute period of
TBI will avoid a progressive cognitive impairment in the future.
Keywords
traumatic brain injury; cognitive impairment; Neiromidin®; neuroplasticity
No comments:
Post a Comment